CASE DISCUSSION
Chronic Kidney Diseases
Presented India by Dr. Satyanarayana GarreViews
11,207
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
Chronic kidney disease involves a gradual loss of kidney function. Your kidneys filter wastes and excess fluids from your blood, which are then removed in your urine. Advanced chronic kidney disease can cause dangerous levels of fluid, electrolytes and wastes to build up in your body. In the early...
Case Summary
- Chronic Kidney Disease (CKD) is defined by a glomerular filtration rate (GFR) less than 60 mL/min/1.73 m² persisting for over 3 months, with or without kidney damage signs. Kidney damage evidence includes proteinuria (albumin creatinine ratio > 30 mg/g) and pathological or structural abnormalities. Kidney failure, End-Stage Renal Disease (ESRD), and uremia, while often used interchangeably, are distinct. Kidney failure is a severe form of CKD where the kidney cannot maintain homeostasis of fluids, electrolytes, hormones, and metabolism. ESRD is CKD stage 5, requiring dialysis or kidney transplant. Uremia refers to the symptoms resulting from urea and creatinine buildup due to kidney failure.
Speaker Profile
Dr. Satyanarayana Garre
MBBS, MD, DNB( Nephrology) Apollo hospitals HyderabadDr. Satyanarayana Garre is a Nephrologist associated with Apollo Hospitals with expertise in kidney diseases and renal care.
He holds MBBS, MD, and DNB in Nephrology, reflecting advanced training in internal medicine and nephrology.
His clinical interests include chronic kidney disease, dialysis management, hypertension, electrolyte disorders, and preventive renal healthcare.
He is committed to providing evidence-based and patient-centered nephrology care using advanced diagnostic and treatment approaches.
Through his clinical practice, he contributes to improving kidney health outcomes and comprehensive renal care services.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.